LoginSignup
Simulations Plus logo

Simulations Plus

Stock
Stock
ISIN: US8292141053
Ticker: SLP
US8292141053
SLP

Price

Price

Historical dividends and forecast

All dividend data

Simulations Plus has so far distributed $0.18 in 2024. The next dividend will be paid on 05.02.2025

$0.222

CHART BY

Frequently asked questions

What is Simulations Plus's market capitalization?

The market capitalization of Simulations Plus is $602.82M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Simulations Plus's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Simulations Plus is 61.38. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Simulations Plus?

Simulations Plus's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.489. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Simulations Plus's stock?

Currently, 3 analysts cover Simulations Plus's stock, with a consensus target price of $60.33. Analyst ratings provide insights into the stock's expected performance.

What is Simulations Plus's revenue over the trailing twelve months?

Over the trailing twelve months, Simulations Plus reported a revenue of $70.01M.

What is the EBITDA for Simulations Plus?

Simulations Plus's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $11.80M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Simulations Plus?

Simulations Plus has a free cash flow of $4.22M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Simulations Plus's stock?

The 5-year beta for Simulations Plus is 0.73. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Simulations Plus have, and what sector and industry does it belong to?

Simulations Plus employs approximately 243 people. It operates in the Health Care sector, specifically within the Software & Programming industry.

What is the free float of Simulations Plus's shares?

The free float of Simulations Plus is 16.43M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $602.82M

5Y beta

 0.73

EPS (TTM)

 $0.489

Free Float

 16.43M

P/E ratio (TTM)

 61.38

Revenue (TTM)

 $70.01M

EBITDA (TTM)

 $11.80M

Free Cashflow (TTM)

 $4.22M

Pricing

52W span
$27.07$51.22

Analyst Ratings

The price target is $60.33 and the stock is covered by 3 analysts.

Buy

3

Hold

0

Sell

0

Information

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The Company’s comprehensive bio simulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. It operates through two segments: software and services. It offers software products for pharmaceutical research, development, and commercialization, including GastroPlus, DDDPlus, MembranePlus, ADMET Predictor, MedChem Designer, DILIsym, NAFLDsym, ILDsym, IPFsym and others. In addition, it also delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development.

243

Software & Programming

Health Care

Identifier

ISIN

US8292141053

Primary Ticker

SLP
Join the conversation
Sign upLogin